Gronkowski Expected to Use Toradol in Super Bowl
With Super Bowl XLVI around the corner, sports pages are abuzz with predictions for both contenders.
One topic on many fans’ minds specifically, is the fate of New England Patriots tight end Rob Gronkowski. After sustaining a high ankle injury during last Sunday’s AFC Championship Game, Gronkowski will almost certainly not be playing at his best this Sunday, doctors and players who have dealt with the injury in the past say. Doctors also expect that Gronkowski will be given the drug Toradol to manage the pain. However, even with the help of the anti-inflammatory, many in the league still have reservations about the effectiveness of Gronkowski’s playing and the long-term damage the big game could do to his ligaments. The Boston Herald reports, “‘It’s not a miracle drug,’ said former Patriots fullback Heath Evans, who indicated he used Toradol for neck trouble last season. ‘It’s not, “Oh I can’t play, and now I can.” This is just something that takes the edge off. That’s it.’”
The article also notes that the NFL has recently come under scrutiny for its excessive use of Toradol. While the drug helps to numb pain, it also makes it harder for players to recognize injuries – a side effect especially dangerous in a contact sport as rough as football. At least part of the heat on the NFL has come from Seeger Weiss LLP. In December, the law firm used its expertise in drug injury to file a lawsuit against the NFL on behalf of 11 former professional players, who say they have suffered brain damage after being given Toradol to treat concussions. Those who have been harmed after receiving Toradol for a sports injury can contact Seeger Weiss LLP by phone or online. The firm’s drug injury lawyers will review any claim for free.
In a Feb. 1 settlement, German automaker Volkswagen agreed to fully compensate American consumers who purchased 3.0-liter diesel engine vehicles equipped with the company’s rigged “clean diesel” emissions testing devices. The company [...]February 3, 2017 By: Seeger Weiss read more
On January 24, the Supreme Court of New Jersey unanimously restored a $25 million verdict for a Seeger Weiss LLP client who sued the drug manufacturer Hoffmann-La Roche after suffering side effects [...]January 30, 2017 By: Seeger Weiss read more